Skip to main content

Table 1 Clinical and demographic characteristics of 117 participants at time of inclusion

From: Evaluation of the effect of supervised anti-malarial treatment on recurrences of Plasmodium vivax malaria

Variable

Total

Supervised

Unsupervised

n = 117

n = 56 (47.8%)

n = 61 (52.2%)

Age (±SD)

38.3 (14.4)

36.6 (14.3)

39.9 (14.6)

Gender (F) 

41/117 (35.0%)

21/56 (37.5%)

20/61 (32.8%)

Education level

 Incomplete primary school

36/117 (30.8%)

14/56 (25.0%)

22/61 (36.1%)

 Complete primary school

14/117 (12.0%)

4/56 (7.1%)

10/61 (16.4%)

 Incomplete high school

29/117 (24.8%))

14/56 (25.0%)

15/61 (24.6%)

 Complete high school

27/117 (23.1%)

15/56 (26.8%)

12/61 (19.7%)

 Bachelor’s degree

11/117 (9.4%)

9/56 (16.1%)

2/61 (3.3%)

Area of residence

 Rural

98/117 (83.8%)

45/56 (80.4%)

53/61 (86.9%)

 Urban

19/117 (16.2%)

11/56 (19.6%)

8/61 (13.1%)

Parasitaemia

 < +/2 

20/117 (17.1%)

11/56 (19.6%)

9/61 (14.8%)

 +/2

15/117 (12.8%)

9/56 (16.1%)

6/61 (9.8%)

 +

26/117 (22.2%)

11/56 (19.6%) 

15/61 (24.6%)

 ++

56/117 (47.9%)

25/56 (44.6%)

31/61 (50.8%)

  1. SD standard deviation, F female
  2. Parasitemia described by the Brazilian Ministry of Health: < +/2 = less than 40 parasites in the 100 fields examined, +/2 = 40 to 60 parasites in 100 microscopic fields, + = 1 parasite per field, ++ = 2 to 20 parasites per field, parasites/µL